Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Novavax Stock Sank Again on Tuesday

TheMotleyFool

0 0

It's only Tuesday, but Novavax (NASDAQ: NVAX) is already having an ugly week. After its stock sank on Monday despite a not-bad first-quarter earnings report, on Tuesday, it was hit by an analyst's price target cut and the shares plummeted again, closing the session almost 14% lower.

In his new research note, Jefferies (NYSE: JEF) prognosticator Kelechi Chikere sliced his price target on Novavax stock from $310 to $235. Since the new target figure is still 70% above the most recent closing share price, Chikere is maintaining his buy recommendation.

Image source: Getty Images.

Source Fool.com

Like: 0

NVAX

Teilen